Determinazione di Morte con Standard Neurologico
New recommendations on metabolic syndrome treatment and acknowledgement of a place for stenting in the management of symptomatic carotid stenosis are among the changes seen in updated secondary stroke prevention guidelines from the American Heart Association (AHA)/American Stroke Association (ASA).
Continue reading about AHA/ASA Releases Updated Secondary Stroke Prevention Guidelines
Emma Hitt, PhD Chest compressions should be the first step in addressing cardiac arrest. Therefore, the American Heart Association (AHA) now recommends that the A-B-Cs (Airway-Breathing-Compressions) of cardiorespiratory resuscitation (CPR) be changed to C-A-B (Compressions-Airway-Breathing).
Continue reading about 2010 AHA Guidelines: The ABCs of CPR Rearranged to “CAB”
Fluoxetine given soon after an ischemic stroke improves motor function in patients with severe motor deficits and increases the number of patients who are independent at 90 days, the results of a new trial show.
Continue reading about Fluoxetine Improves Motor Function After Ischemic Stroke
Negli individui con valori glicemici plasmatici sia a digiuno (Fpg) sia a due ore dal carico compresi nel range di normalità, un alto livello di glicemia a due ore è associato a insulinoresistenza e ad aumentata mortalità cardiovascolare.
Continue reading about Acs: il rigurgito mitralico ha valore prognostico long-term
In a prospective, randomized study, patients with suspected sepsis who received a bolus of etomidate before rapid sequence intubation spent no more time in the hospital than similar patients who received a bolus of midazolam.
Dopo un ricovero ospedaliero per infarto miocardico (Ima), l’impiego di inibitori di pompa protonica (Ppi) sembra associarsi a un rischio maggiore di esiti cardiovascolari avversi, indipendentemente dall’uso di clopidogrel. L’utilizzo combinato di Ppi e clopidogrel non è associato ad alcun rischio aggiuntivo per eventi avversi cardiovascolari rispetto a quelli osservati in caso di monoterapia con [...]
Continue reading about Post-infarto, rischio maggiore con inibitori di pompa protonica
The largest clinical trial to date of out-of-hospital hypertonic resuscitation shows it does not improve outcomes after traumatic brain injury. The disappointing results call into question the idea of emergency-response fluid intervention.
Continue reading about Emergency Hypertonic Fluids Fail to Improve Brain Injury Outcome
Leggi l’articolo intero: Pulmonary Vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review
Leggi l’articolo intero.
Continue reading about Early mobilization improves functional outcomes in critically ill patients
Sono state presentate a Stoccolma, nel corso del Congresso annuale della Società europea di cardiologia (Esc). Molti i nuovi concetti classificativi, come spiega Antonio Raviele, direttore del Dipartimento cardiovascolare dell’Ospedale dell’Angelo di Mestre.
Continue reading about Nuove linee guida europee per la fibrillazione
Nei pazienti con fibrillazione atriale (Fa), che spesso necessitano di una terapia anticoagulante e antipiastrinica, il ricorso a una monoterapia è preferibile, in termini di sicurezza, rispetto a trattamenti basati su due o tre farmaci.
Continue reading about Monoterapia antiaggregante associata a meno emorragie
The Role of Diffusion and Perfusion MRI for the diagnosis of Acute Ischemic Stroke
Atherothrombosis is an underlying condition that results in myocardial infarction (MI), ischemic stroke, and death.[1,2] As such, atherothrombosis is the leading cause of mortality in the United States, resulting in 36% of the deaths that occur.[3] Platelet activation and aggregation play a pivotal role in the pathophysiology of ischemic complications of atherothrombotic cardiovascular disease (CVD). [...]
Continue reading about Antiplatelet Strategies to Protect ACS Patients and Minimize Risk
Thrombosis is a major cause of morbidity and mortality worldwide. Traditional anticoagulant therapies (heparin and warfarin), although efficacious, are associated with limitations in their utility for long-term administration. Consequently, there is an ongoing search for new anticoagulant agents. A better understanding of the biochemical pathways involved in coagulation has led to the identification of new [...]
